Bloomberg News

Serb Galenika Says It Secures Certificate for Drug Sales in EU

June 13, 2013

Galenika AD, Serbia’s state-owned drugmaker, said it received a compliance certificate for non-sterile products that allows their sales in the European Union.

Painkillers, anti-coagulants, anti-anxiety and diabetes drugs, exported so far to non-EU neighbors and Russia, will also be offered in Asia and Africa, following the approval by regulator in EU member Slovenia, the company said in an e-mailed statement.

To contact the reporter on this story: Misha Savic in Belgrade at

To contact the editor responsible for this story: James M. Gomez at

Toyota's Hydrogen Man
blog comments powered by Disqus